Financial News

AMSTERDAM — Keeping stores open during Hurricane Sandy was one of the factors that contributed to an increase in total store sales and comps in the fourth quarter and fiscal year 2012 for Ahold USA, the supermarket operator's Dutch parent company said Thursday.

Ahold attributed its 4.3% increase in sales in the fourth quarter, to $6.1 billion, partially to the Hurricane Sandy effort. The quarter also saw comps increase by 2.4%, while full year sales were $25.8 billion, a 3.1% over 2011, as comps increased by 1.4%.

PITTSBURGH — Mylan has bought a manufacturer of generic injectables for $1.6 billion, the company said.

Mylan announced the acquisition of Bangalore, India-based Agila from Strides Arcolab, which Mylan said would allow it to strengthen its injectables business and enter new markets around the world.

CHESAPEAKE, Va. — Dollar Tree reported consolidated net sales for the fourth-quarter jumped 15.4% to $2.25 billion compared with $1.95 billion reported for the quarter ended Jan. 28, 2012. Comparable-store sales increased 2.4%, on top of a 7.3% increase for the fourth quarter 2011.

Earnings per diluted share for the fourth quarter were $1.01, an increase of 26.3% compared with the 80 cents earnings per diluted share reported for the fourth quarter 2011.

NEW YORK — According to published reports, Flowers Foods is set to buy Hostess bread brands, including Wonder bread, for $360 million after no other bidder came forward with a competing offer, a source familiar with the sale acknowledged Wednesday.

According to a Reuters report, Hostess, which went bankrupt last year, was scheduled to host an auction on Thursday for the brands — which also include Butternut, Home Pride, Merita and Nature's Pride — but as no other bids were announced, the company will not go through with an auction.

MINNEAPOLIS — Target is planning a rollout in Canada that will be bigger than any single year's worth of its store openings in the United States ever, executives of the company said Wednesday morning in a call with Wall Street analysts to discuss the mass merchandise retailer's fourth-quarter and full-year 2012 results.

NEW YORK — A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan, but hasn't heard back from it, according to published reports.

The Associated Press reported that Royalty Pharma's $11-per-share offer for Elan represented a 4% premium over its closing price Friday. Royalty buys royalty interests in drug products that are in late-stage development or have already entered the market, but doesn't develop or market drugs of its own, the AP reported.

Sore throats and dry coughs are more prevalent symptoms associated with the flu. With the severe 2012-2013 flu season to date, that means a healthy amount of lozenge sales. One of the bigger winners across the top 10 vendors is Reckitt Benckiser, which launched Cepacol Sensations this fall. The product line contains a lower amount of numbing medication than traditional Cepacol products, yet still provides either an instantly cooling, warming or refreshing sensation. Sales of all Reckitt Benckiser lozenges totaled $10.9 million, up 67.6%.

Consumers still have a thirst for bottled water. "Bottled water is performing moderately well with respectable growth," said John Sicher, publisher of Beverage Digest. Dollar sales of bottled water were up 7% across food, drug and mass outlets for the 52 weeks ended Dec. 2, 2012, according to SymphonyIRI data. Sicher said he expects bottled water to grow modestly over the next few years.